Clinical Trial Update: The DENOCHARCOT Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial named DENOCHARCOT is currently recruiting to study treatment for Charcot neuroarthropathy in people with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot Neuroarthropathy
• Diabetes Mellitus

Snippet

Sponsor: Ole Lander Svendsen | Conditions: Charcot Foot, Diabetes Mellitus | Phase 3 | Status: RECRUITING